- Filed
- Nov 4, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 1, 2024 | 305.68M sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $149.37K |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $41.01K |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $1.96M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $1.5M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $4M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $4.59M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $216.36K |
| Current Assets | Q3 2024 · Dec 31, 2023 | $76.76K |
| Total Assets | Q3 2024 · Sep 30, 2024 | $1.49M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $1.03M |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 299.75M sh |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 299.75M sh |
| Capex | Q3 2024 · Sep 30, 2023 | $282.04K |
| Operating Cash Flow restated | Q3 2024 · Sep 30, 2023 | −$1.49M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | −$3.09M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | −$3.09M |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | −$2.35M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | −$2.36M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.00 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.01 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$0.00 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$0.01 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $219.16K |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $943.95K |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $293.67K |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $1.74M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$332K |
| Net Income | Q3 2024 · Sep 30, 2023 | −$2.55M |
| Net Income | Q3 2024 · Jun 30, 2023 | −$1.15M |
| Net Income | Q3 2024 · Mar 31, 2023 | −$1.06M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$512.83K |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$2.69M |